The Effects of Cigarette Addiction on Lower Extremity Movement Speed and Coordination
1 other identifier
observational
24
1 country
1
Brief Summary
This observational study will aim to investigate the effects of cigarette addiction on lower extremity motor coordination and movement speed in young adults. The study will include healthy participants aged 18-25 years, divided into smokers and non-smokers. Motor coordination will be assessed using the Lower Extremity Motor Coordination Test (LEMOCOT), and speed will be evaluated with a 30-meter sprint test. Nicotine dependence will be evaluated in smokers using the Fagerström Test. The findings will provide insight into the possible functional impacts of nicotine addiction on motor performance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jul 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 10, 2025
CompletedFirst Posted
Study publicly available on registry
July 20, 2025
CompletedStudy Start
First participant enrolled
July 29, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 20, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 20, 2026
July 30, 2025
July 1, 2025
12 months
July 10, 2025
July 29, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
LEMOCOT Score (Lower Extremity Motor Coordination Test)
The number of correct taps within 20 seconds will be measured for each participant.
Baseline
30-Meter Sprint Time
Time (in seconds) required to complete a 30-meter sprint will be recorded and averaged from two trials.
Baseline
Secondary Outcomes (3)
Fagerström Test for Nicotine Dependence Score
Baseline
Body Mass Index (BMI)
Baseline
Bimalleolar Circumference and Diameter Measurement
Baseline
Study Arms (2)
Smokers
Individuals who will meet WHO and DSM-IV-TR criteria for cigarette dependence.
Non-Smokers
Individuals who will report no smoking behavior in the past year.
Interventions
This study will include only observational functional assessments. No active intervention will be performed.This observational protocol will involve standardized assessments of lower extremity coordination (LEMOCOT), movement speed (30-meter sprint), and smoking-related behavioral patterns (Fagerström Test for Nicotine Dependence). These tools will be used to evaluate the potential impact of cigarette addiction on physical performance in young adults. No therapeutic or pharmacological intervention will be applied.
Eligibility Criteria
The study population will consist of healthy young adults aged between 18 and 25 years. A total of 24 participants will be included, with 12 individuals who meet the criteria for cigarette dependence and 12 who do not smoke. Participants will be recruited from a university setting using convenience and snowball sampling methods. All participants will be required to be cooperative, literate, and able to walk independently. They will also be screened to ensure a body mass index (BMI) between 18.5 and 29.9 kg/m². Smokers will be identified based on the World Health Organization (WHO) definition and the DSM-IV-TR diagnostic criteria. Individuals with orthopedic, neurologic, cardiopulmonary, or cognitive impairments will be excluded.
You may qualify if:
- Age between 18 and 25 years
- Able to walk independently
- Literate and cooperative
- Willing to participate voluntarily
- BMI between 18.5 and 29.9 kg/m²
- Daily smoking for at least one year based on WHO and DSM-IV-TR definitions
You may not qualify if:
- Orthopedic, neurologic, or neuromuscular disorders affecting gait
- Chronic cardiopulmonary disease
- Cognitive impairments
- Obesity (BMI ≥ 30 kg/m²)
- History of acute cardiovascular events
- Chronic heart failure or lung diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Esra Pehlivan
Istanbul, Üsküdar, 34668, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 10, 2025
First Posted
July 20, 2025
Study Start
July 29, 2025
Primary Completion (Estimated)
July 20, 2026
Study Completion (Estimated)
July 20, 2026
Last Updated
July 30, 2025
Record last verified: 2025-07